ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About ZhuZhou QianJin Pharmaceutical Co.,Ltd
—
ZhuZhou QianJin Pharmaceutical Co.,Ltd is led by CEO Zhiyong Chen, employs 5,041 people, headquartered in Zhuzhou, CN, publicly traded since 2004.
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) stock trades at $10.84 with a market capitalization of $7.29B. The stock is valued at a price-to-earnings (P/E) ratio of 20.29, price-to-book of 2.41, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $9.20 and $15.25, and currently trades 28.9% below its 52-week high. It pays a dividend yielding 2.74%.
On profitability, ZhuZhou QianJin Pharmaceutical Co.,Ltd generates a return on equity (ROE) of 12.34%, an operating margin of 15.34%, a net profit margin of 9.10%.
Official website: www.qjyy.com
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) — frequently asked questions
What is ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) stock price today?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) is currently trading at $10.84, down 1.81% today.
What is 600479.SS P/E ratio?
ZhuZhou QianJin Pharmaceutical Co.,Ltd's P/E ratio is 20.29. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 600479.SS return on equity (ROE)?
ZhuZhou QianJin Pharmaceutical Co.,Ltd's return on equity (ROE) is 12.34%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.
What is ZhuZhou QianJin Pharmaceutical Co.,Ltd's market cap?
ZhuZhou QianJin Pharmaceutical Co.,Ltd has a market capitalization of $7.29B.
Does 600479.SS pay a dividend?
Yes. ZhuZhou QianJin Pharmaceutical Co.,Ltd currently yields 2.74%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600479.SS carry?
ZhuZhou QianJin Pharmaceutical Co.,Ltd has a debt-to-equity ratio of 0.05. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600479.SS's profit margin?
ZhuZhou QianJin Pharmaceutical Co.,Ltd reports a net profit margin of 9.10% — the share of revenue left after every cost, including tax and interest.
What sector is 600479.SS in?
ZhuZhou QianJin Pharmaceutical Co.,Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600479.SS listed on?
ZhuZhou QianJin Pharmaceutical Co.,Ltd trades on SHH under the ticker 600479.SS.
What is 600479.SS's 52-week range?
Over the last year ZhuZhou QianJin Pharmaceutical Co.,Ltd has traded between $9.20 and $15.25.
Related — Stocks
Popular Stocks
Screens 600479.SS currently matches
On the figures above, ZhuZhou QianJin Pharmaceutical Co.,Ltd passes the filters for 9 of our ready-made screens, among them Dividend Stocks, Low Debt Dividend Stocks, Low Debt Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.